ZA932312B - 3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them. - Google Patents
3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them.Info
- Publication number
- ZA932312B ZA932312B ZA932312A ZA932312A ZA932312B ZA 932312 B ZA932312 B ZA 932312B ZA 932312 A ZA932312 A ZA 932312A ZA 932312 A ZA932312 A ZA 932312A ZA 932312 B ZA932312 B ZA 932312B
- Authority
- ZA
- South Africa
- Prior art keywords
- tert
- butyl
- preparation
- compositions containing
- hydroxy flavones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9203861A FR2689127B1 (fr) | 1992-03-31 | 1992-03-31 | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA932312B true ZA932312B (en) | 1993-10-18 |
Family
ID=9428265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA932312A ZA932312B (en) | 1992-03-31 | 1993-03-31 | 3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them. |
Country Status (13)
Country | Link |
---|---|
US (2) | US5280024A (es) |
EP (1) | EP0564350B1 (es) |
JP (1) | JPH07119221B2 (es) |
AT (1) | ATE153022T1 (es) |
AU (1) | AU655106B2 (es) |
CA (1) | CA2092961A1 (es) |
DE (1) | DE69310602T2 (es) |
DK (1) | DK0564350T3 (es) |
ES (1) | ES2104090T3 (es) |
FR (1) | FR2689127B1 (es) |
GR (1) | GR3023938T3 (es) |
NZ (1) | NZ247287A (es) |
ZA (1) | ZA932312B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2689127B1 (fr) * | 1992-03-31 | 1994-05-06 | Adir Cie | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
WO1996031206A2 (en) * | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
DE19638515B4 (de) * | 1996-09-20 | 2004-01-15 | Grundig Car Intermedia System Gmbh | Verfahren und Vorrichtung zur Zuordnung von Nachrichten, insbesondere Verkehrsnachrichten |
FR2753969B1 (fr) * | 1996-09-27 | 1998-10-30 | Adir | Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
US6028088A (en) * | 1998-10-30 | 2000-02-22 | The University Of Mississippi | Flavonoid derivatives |
EP1127572A3 (en) * | 2000-02-25 | 2003-05-02 | Basf Aktiengesellschaft | Use of flavones for treating cycloxygenase-2 mediated diseases |
FR2815033B1 (fr) | 2000-10-06 | 2003-09-05 | Negma Lab | Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique |
US6818668B2 (en) | 2002-04-12 | 2004-11-16 | Biotest Laboratories, Llc | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method |
GB0216371D0 (en) | 2002-07-13 | 2002-08-21 | Rowett Res Inst The | Compounds |
DE10232595A1 (de) * | 2002-07-18 | 2004-02-05 | Merck Patent Gmbh | Lichtschutzmittel |
EP2332527A3 (en) | 2004-10-20 | 2011-11-16 | Resverlogix Corp. | Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases |
KR100729731B1 (ko) * | 2005-07-19 | 2007-06-20 | 건국대학교 산학협력단 | 사람 피부 세포의 세포사멸을 억제하는 활성을 갖는플라보노이드 |
KR101431279B1 (ko) * | 2005-07-29 | 2014-08-20 | 리스버로직스 코퍼레이션 | 복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달 |
PL2118074T3 (pl) | 2007-02-01 | 2014-06-30 | Resverlogix Corp | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego |
NZ586440A (en) | 2008-06-26 | 2011-07-29 | Resverlogix Corp | Methods of preparing quinazolinone derivatives |
ES2463097T3 (es) | 2009-01-08 | 2014-05-27 | Resverlogix Corp. | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
NZ596117A (en) | 2009-04-22 | 2014-10-31 | Resverlogix Corp | Novel anti-inflammatory agents |
GB201017315D0 (en) | 2010-10-13 | 2010-11-24 | Antoxis Ltd | Compound |
HUE044986T2 (hu) | 2011-11-01 | 2019-11-28 | Resverlogix Corp | Orális, azonnali felszabadulású készítmények szubsztituált kinazolinonokhoz |
WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
KR20150096794A (ko) | 2012-12-21 | 2015-08-25 | 제니쓰 에피제네틱스 코포레이션 | 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물 |
CN114984016A (zh) | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1247909A (fr) * | 1955-11-02 | 1960-12-09 | Recordati Lab Farmacologico Dr | Procédé de préparation des dérivés d'hydroxychromones |
DE1054091B (de) * | 1958-05-30 | 1959-04-02 | Chemiewerk Homburg Ag | Verfahren zur Herstellung von N-substituierten 2-Phenyl-7-aminoalkoxy-chromonen |
DE1418516A1 (de) * | 1959-07-28 | 1968-12-05 | Klosa Dipl Chem Dr Josef | Verfahren zur Herstellung von Flavon-7-oxyessigsaeureamiden |
GB1250388A (es) * | 1968-11-27 | 1971-10-20 | ||
DE2029658A1 (de) * | 1970-06-16 | 1971-12-23 | Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof | 2 (4 Oxo-4H 1 benzopyran 7 yl) oxy isobutter saure Derivate und Verfahren zur Herstellung derselben |
US3816466A (en) * | 1971-12-22 | 1974-06-11 | Warner Lambert Co | Flavanoid ring systems |
JPH02214780A (ja) * | 1989-02-14 | 1990-08-27 | San Ei Chem Ind Ltd | アントシアン色素の安定化法 |
JPH035423A (ja) * | 1989-06-01 | 1991-01-11 | Ichimaru Pharcos Co Ltd | フラボノイド含有過酸化脂質生成抑制剤 |
DE4011187A1 (de) * | 1990-04-06 | 1991-10-10 | Hoechst Ag | Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte |
AU631860B2 (en) * | 1990-04-06 | 1992-12-10 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara | An improved process for the preparation of substituted isoflavone derivatives |
EP0558245A1 (en) * | 1992-02-25 | 1993-09-01 | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY | Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors |
FR2689127B1 (fr) * | 1992-03-31 | 1994-05-06 | Adir Cie | Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
-
1992
- 1992-03-31 FR FR9203861A patent/FR2689127B1/fr not_active Expired - Fee Related
-
1993
- 1993-03-25 US US08/036,814 patent/US5280024A/en not_active Expired - Fee Related
- 1993-03-30 AT AT93400811T patent/ATE153022T1/de not_active IP Right Cessation
- 1993-03-30 AU AU35591/93A patent/AU655106B2/en not_active Ceased
- 1993-03-30 DE DE69310602T patent/DE69310602T2/de not_active Expired - Fee Related
- 1993-03-30 EP EP93400811A patent/EP0564350B1/fr not_active Expired - Lifetime
- 1993-03-30 ES ES93400811T patent/ES2104090T3/es not_active Expired - Lifetime
- 1993-03-30 DK DK93400811.1T patent/DK0564350T3/da active
- 1993-03-30 CA CA002092961A patent/CA2092961A1/fr not_active Abandoned
- 1993-03-30 JP JP5072457A patent/JPH07119221B2/ja not_active Expired - Lifetime
- 1993-03-30 NZ NZ247287A patent/NZ247287A/en unknown
- 1993-03-31 ZA ZA932312A patent/ZA932312B/xx unknown
- 1993-08-18 US US08/108,333 patent/US5457103A/en not_active Expired - Fee Related
-
1997
- 1997-06-30 GR GR970401586T patent/GR3023938T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ247287A (en) | 1994-08-26 |
ES2104090T3 (es) | 1997-10-01 |
DE69310602T2 (de) | 1997-12-18 |
EP0564350B1 (fr) | 1997-05-14 |
CA2092961A1 (fr) | 1993-10-01 |
JPH07119221B2 (ja) | 1995-12-20 |
JPH0625212A (ja) | 1994-02-01 |
US5280024A (en) | 1994-01-18 |
ATE153022T1 (de) | 1997-05-15 |
AU655106B2 (en) | 1994-12-01 |
FR2689127B1 (fr) | 1994-05-06 |
EP0564350A1 (fr) | 1993-10-06 |
AU3559193A (en) | 1993-10-07 |
DE69310602D1 (de) | 1997-06-19 |
FR2689127A1 (fr) | 1993-10-01 |
GR3023938T3 (en) | 1997-09-30 |
DK0564350T3 (da) | 1997-12-15 |
US5457103A (en) | 1995-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA932312B (en) | 3',5'-Di-tert.-butyl-4'-hydroxy flavones, process for the preparation thereof and pharamceutical compositions containing them. | |
AU580151B2 (en) | 9-(phosphonylmethoxyalkyl) adenines, the method of preparation and utilization thereof | |
GEP20022822B (en) | Process for Preparing Derivatives of the Taxoid Family | |
IL110804A (en) | Triphenyl- methylthiazolidine-2, 4-dione derivatives and processes utilizing the same | |
AU586691B2 (en) | Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them | |
ZA913827B (en) | Process for the enantioselective preparation of phenylisoserine derivatives | |
TW353661B (en) | New derivatives of erythromycin, their preparation process and their use as medicaments | |
AU6826887A (en) | 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates | |
HUT76060A (en) | A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
EP0196330A1 (de) | Verwendung von pyrrothinderivaten. | |
ZA906446B (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
DE3477003D1 (en) | Process for the preparation of 17-alpha-acyloxy-6-chloro-1-alpha,2-alpha-methylene-4,6-pregnadiene-3-20-diones | |
FR2681318B1 (es) | ||
EP0657412A4 (es) | ||
KR910000786A (ko) | 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도 | |
BG102081A (en) | New derivatives of 2-azabicyclo [2.2.1] heptane, their preparation and application | |
UA41309C2 (uk) | ПОХІДНІ 11-<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОТРИМАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ | |
GEP19970664B (en) | Acrylic acid derivatives and stereoisomers | |
CA2056979A1 (en) | Process for the preparation of ketone compounds | |
MX9207565A (es) | Hidroxilacion. |